-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$7.90149.21% Upside
Akoya Biosciences, Inc. Frequently Asked Questions
-
What analysts cover Akoya Biosciences, Inc.?
Akoya Biosciences, Inc. has been rated by research analysts at Morgan Stanley, Craig-Hallum, BTIG, Canaccord Genuity, Piper Sandler in the past 90 days.